Barok M, Le Joncour V, Martins A, Isola J, et al. ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in
preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer
and gastric cancer. Cancer Lett 2020 Jan 2. pii: S0304-3835(19)30659.
PMID: 31904483